{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:24:40Z","timestamp":1740165880226,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-022-00706-1","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T17:23:32Z","timestamp":1652117012000},"page":"494-498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of daprodustat on anemia in hemodialysis patients with sustained inflammation: a case report"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9399-7433","authenticated-orcid":false,"given":"Shoichiro","family":"Daimon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"706_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ki.1984.36","volume":"25","author":"RJ McGonagall","year":"1984","unstructured":"McGonagall RJ, Walling JD, Shadduck RK, Fisher JW. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int. 1984;25:437\u201344.","journal-title":"Kidney Int"},{"key":"706_CR2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/kisup.2012.34","volume":"2","author":"Kidney disease improving global outcomes (KDIGO)","year":"2012","unstructured":"Kidney disease improving global outcomes (KDIGO). Clinical practice guideline for anemia in chronic kidney disease. Kidney Int. 2012;2:292\u20138.","journal-title":"Kidney Int"},{"key":"706_CR3","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1021\/acs.jmedchem.7b01686","volume":"61","author":"AA Joharapurkar","year":"2018","unstructured":"Joharapurkar AA, Pandya VB, Patel VJ, Desai RC, Jain MR. Prolyl hydroxylase inhibitors: a breakthrough in the therapy of anemia associated with chronic diseases. J Med Chem. 2018;61:6964\u201382.","journal-title":"J Med Chem"},{"key":"706_CR4","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2215\/CJN.16011219","volume":"15","author":"T Akizawa","year":"2020","unstructured":"Akizawa T, Nangaku M, Yonekawa T, et al. Efficacy and safety of daprodustat compared with darbepoetin alfa in Japanese hemodialysis patients with anemia: a randomized, double-blind, phase 3 trial. Clin J Am Soc Nephrol. 2020;15:1155\u201365.","journal-title":"Clin J Am Soc Nephrol"},{"key":"706_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJM199808273390903","volume":"339","author":"A Besarab","year":"1998","unstructured":"Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339:584\u201390.","journal-title":"N Engl J Med"},{"key":"706_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.dmpk.2015.08.004","volume":"30","author":"K Hara","year":"2015","unstructured":"Hara K, Takahashi N, Wakamatsu A, Caltabiano S. Pharmacokinetics, pharmacodynamics and safety of single, oral doses of GSK1278863, a novel HIF-prolyl hydroxylase inhibitor, in healthy Japanese and Caucasian subjects. Drug Metab Pharmacokinet. 2015;30:410\u20138.","journal-title":"Drug Metab Pharmacokinet"},{"key":"706_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1681\/ASN.2015091009","volume":"27","author":"CR Lenihan","year":"2016","unstructured":"Lenihan CR, Winkelmayer WC. The dawning of a new day in CKD anemia care? J Am Soc Nephrol. 2016;27:968\u201370.","journal-title":"J Am Soc Nephrol"},{"key":"706_CR8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/1744-9987.13537","volume":"24","author":"S Daimon","year":"2020","unstructured":"Daimon S. Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator. Ther Apher Dial. 2020;24:602\u20136.","journal-title":"Ther Apher Dial"},{"key":"706_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","volume":"133","author":"G Weiss","year":"2019","unstructured":"Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133:40\u201350.","journal-title":"Blood"},{"key":"706_CR10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/1744-9987.13483","volume":"24","author":"S Daimon","year":"2020","unstructured":"Daimon S. Shortened red cell life span as a factor of anemia of mild inflammation in hemodialysis patients. Ther Apher Dial. 2020;24:742\u20134.","journal-title":"Ther Apher Dial"},{"key":"706_CR11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1681\/ASN.V781178","volume":"7","author":"M Poienakovic","year":"1996","unstructured":"Poienakovic M, Sikole A. Is erythropoietin a survival factor for red blood cells? J Am Soc Nephrol. 1996;7:1178\u201382.","journal-title":"J Am Soc Nephrol"},{"key":"706_CR12","doi-asserted-by":"publisher","first-page":"c149","DOI":"10.1159\/000104425","volume":"106","author":"CP Alfrey","year":"2007","unstructured":"Alfrey CP, Fishbane S. Implications of neocytolysis for optimal management of anaemia in chronic kidney disease. Nephron Clin Pract. 2007;106:c149-156.","journal-title":"Nephron Clin Pract"},{"key":"706_CR13","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1080\/0886022X.2021.1988968","volume":"43","author":"X Yang","year":"2021","unstructured":"Yang X, Zhao B, Wang J, et al. Red blood cell lifespan in long-term hemodialysis patients treated with roxadustat or recombinant human erythropoietin. Ren Fail. 2021;43:1428\u201336.","journal-title":"Ren Fail"},{"key":"706_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.ajkd.2011.03.031","volume":"58","author":"FE Vos","year":"2011","unstructured":"Vos FE, Schollum JB, Coulter CV, Doyle TCA, Duffull SB, Walker RJ. Red blood cell survival in long-term dialysis patients. Am J Kidney Dis. 2011;58:591\u20138.","journal-title":"Am J Kidney Dis"},{"key":"706_CR15","first-page":"711","volume":"62","author":"K Uchida","year":"2020","unstructured":"Uchida K, Nangaku M, Abe M, et al. HIF-PH_recommendation. Jpn J Nephrol. 2020;62:711\u20136 (in Japanese).","journal-title":"Jpn J Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00706-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-022-00706-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00706-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T20:46:44Z","timestamp":1667335604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-022-00706-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["706"],"URL":"https:\/\/doi.org\/10.1007\/s13730-022-00706-1","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number 2022 A-1) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}